LV10200A - Himopapains to saturosas farmaceitiskas kompozicijas to pielietojums panemiens himopapaina attirisanai inhibejosie peptidi un afinas hromatografijas matricas - Google Patents

Himopapains to saturosas farmaceitiskas kompozicijas to pielietojums panemiens himopapaina attirisanai inhibejosie peptidi un afinas hromatografijas matricas

Info

Publication number
LV10200A
LV10200A LV930624A LV930624A LV10200A LV 10200 A LV10200 A LV 10200A LV 930624 A LV930624 A LV 930624A LV 930624 A LV930624 A LV 930624A LV 10200 A LV10200 A LV 10200A
Authority
LV
Latvia
Prior art keywords
himopapic
anthelmintic
inhibition
formulation
pharmaceutical compositions
Prior art date
Application number
LV930624A
Other languages
English (en)
Other versions
LV10200B (en
Inventor
Alan John Barret
David John Buttle
Daniel Hulbert Rich
Original Assignee
Boots Co Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co Plc filed Critical Boots Co Plc
Publication of LV10200A publication Critical patent/LV10200A/lv
Publication of LV10200B publication Critical patent/LV10200B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
LVP-93-624A 1989-04-28 1993-06-19 Therapeutic agent LV10200B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898909836A GB8909836D0 (en) 1989-04-28 1989-04-28 Therapeutic agent
PCT/EP1990/000647 WO1990013561A1 (en) 1989-04-28 1990-04-27 Therapeutic agent

Publications (2)

Publication Number Publication Date
LV10200A true LV10200A (lv) 1994-10-20
LV10200B LV10200B (en) 1995-04-20

Family

ID=10655944

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-93-624A LV10200B (en) 1989-04-28 1993-06-19 Therapeutic agent

Country Status (34)

Country Link
US (2) US5380656A (lv)
EP (1) EP0470136B1 (lv)
JP (1) JPH04506003A (lv)
KR (1) KR920701241A (lv)
CN (1) CN1047340A (lv)
AT (1) ATE107660T1 (lv)
AU (1) AU631641B2 (lv)
BG (1) BG60916B1 (lv)
CA (1) CA2056402C (lv)
DD (1) DD296960A5 (lv)
DE (1) DE69010199T2 (lv)
DK (1) DK0470136T3 (lv)
EG (1) EG19583A (lv)
ES (1) ES2055427T3 (lv)
FI (1) FI914995A0 (lv)
GB (1) GB8909836D0 (lv)
GR (1) GR1001011B (lv)
HR (1) HRP930700A2 (lv)
HU (2) HUT58345A (lv)
IE (1) IE64351B1 (lv)
IL (1) IL94227A (lv)
IN (2) IN170683B (lv)
LT (1) LT3827B (lv)
LV (1) LV10200B (lv)
MX (1) MX20503A (lv)
NO (1) NO914206L (lv)
NZ (1) NZ233475A (lv)
PL (1) PL166810B1 (lv)
PT (1) PT93921B (lv)
RO (1) RO112032B1 (lv)
RU (1) RU2074891C1 (lv)
WO (1) WO1990013561A1 (lv)
YU (1) YU87090A (lv)
ZA (1) ZA903228B (lv)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8909836D0 (en) * 1989-04-28 1989-06-14 Boots Co Plc Therapeutic agent
JPH06506921A (ja) * 1991-02-22 1994-08-04 ザ・デュポン・メルク・ファーマシュウティカル・カンパニー 置換α−アミノアルデヒドおよび誘導体
CA2061861A1 (en) * 1991-03-04 1992-09-05 Jonathan Duvick Plant polypeptides with inhibitory activity towards pathogenic microorganisms
CN1060519C (zh) * 1991-05-09 2001-01-10 广西亚热带作物研究所 桄榔植物蛋白酶的提取方法
WO1993008404A1 (en) * 1991-10-14 1993-04-29 Cash Engineering Research Pty. Ltd. Inlet control combination for a compressor system
US6753006B1 (en) 1993-02-22 2004-06-22 American Bioscience, Inc. Paclitaxel-containing formulations
WO1994028012A1 (en) * 1993-05-28 1994-12-08 Warner-Lambert Company Hydroxamate inhibitors of endothelin converting enzyme
CA2360740A1 (en) 1999-03-02 2000-09-08 Boehringer Ingelheim Pharmaceuticals, Inc. Compounds useful as reversible inhibitors of cathepsin s
DK1178958T3 (da) 1999-03-15 2004-06-21 Axys Pharm Inc N-cyanomethylamider som proteaseinhibitorer
US6420364B1 (en) 1999-09-13 2002-07-16 Boehringer Ingelheim Pharmaceuticals, Inc. Compound useful as reversible inhibitors of cysteine proteases
US6703040B2 (en) * 2000-01-11 2004-03-09 Intralytix, Inc. Polymer blends as biodegradable matrices for preparing biocomposites
JP4512038B2 (ja) * 2002-12-25 2010-07-28 小森 博達 椎間板変性治療剤
US7169405B2 (en) * 2003-08-06 2007-01-30 Warsaw Orthopedic, Inc. Methods and devices for the treatment of intervertebral discs
US20080069907A1 (en) * 2004-07-06 2008-03-20 Chikao Morimoto Compositions for Cancer Prevention, Treatment, or Amelioration Comprising Papaya Extract
CN1320111C (zh) * 2004-08-09 2007-06-06 王美岭 一种制备木瓜凝乳酶的方法
US20060241566A1 (en) * 2005-04-11 2006-10-26 Orthox, Llc Nucleus Extraction from Spine Intervertebral Disc
US8642060B2 (en) * 2006-04-24 2014-02-04 Warsaw Orthopedic, Inc. Controlled release systems and methods for osteal growth
US7771414B2 (en) * 2006-04-24 2010-08-10 Warsaw Orthopedic, Inc. Controlled release devices for therapeutic treatments of spinal discs
US8642059B2 (en) 2006-04-24 2014-02-04 Warsaw Orthopedic, Inc. Controlled release systems and methods for intervertebral discs
US7879027B2 (en) * 2006-04-24 2011-02-01 Warsaw Orthopedic, Inc. Controlled release devices for fusion of osteal structures
US20070265633A1 (en) * 2006-05-11 2007-11-15 Moon Jon K Implement and method to extract nucleus from spine intervertebral disc
US8257938B2 (en) * 2009-02-27 2012-09-04 Medical Diagnostic Laboratories, Llc Hemolysin and its protein fragments in sero-detection of Anaplasma phagocytophilum
WO2013038936A1 (ja) * 2011-09-13 2013-03-21 タカラバイオ株式会社 ペルオキシダーゼ反応の停止方法及び反応停止剤
US9375519B2 (en) 2012-06-25 2016-06-28 Surmodics, Inc. Bioerodable poly(etheresteramides) and medical article uses

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE270723C (lv) *
US2313875A (en) * 1940-12-17 1943-03-16 Eugene F Jansen Proteolytic enzyme process
US3320131A (en) * 1964-10-23 1967-05-16 Baxter Laboratories Inc Method for the treatment of herniation of intervertebral discs
US3558433A (en) * 1967-11-07 1971-01-26 Baxter Laboratories Inc Process for purification of chymopapain
YU40433B (en) * 1975-02-20 1986-02-28 Lek Tovarna Farmacevtskih Process for obtaining pure, proteolytically active anzymes
DE3212846A1 (de) 1981-04-13 1982-11-04 Sintokogio, Ltd., Nagoya, Aichi Apparat und verfahren zum herstellen eines kerns
US4719108A (en) * 1981-05-13 1988-01-12 Smith Laboratories, Inc. Chymopapain composition and method for its use
US4374926A (en) * 1981-05-13 1983-02-22 Smith Laboratories, Inc. Method for the production of improved chymopapain
US4439423A (en) * 1981-05-13 1984-03-27 Smith Laboratories, Inc. Chymopapain and method for its use
DE3278934D1 (en) * 1981-05-13 1988-09-29 Flint Lab Inc Improved chymopapain and method for its production and use
WO1984000365A1 (en) * 1982-07-19 1984-02-02 Nat Res Dev Synthetic peptides and their preparation
GB2156821A (en) * 1984-04-03 1985-10-16 Simmons James W Process for purifying chymopapain
HU196624B (en) * 1986-12-08 1988-12-28 Chinoin Gyogyszer Es Vegyeszet Process for producing chymopapain with high specific activity
GB8909836D0 (en) * 1989-04-28 1989-06-14 Boots Co Plc Therapeutic agent

Also Published As

Publication number Publication date
NO914206D0 (no) 1991-10-25
HU211746A9 (en) 1995-12-28
US5380656A (en) 1995-01-10
DK0470136T3 (da) 1994-08-01
ATE107660T1 (de) 1994-07-15
HRP930700A2 (en) 1995-06-30
IN170683B (lv) 1992-05-02
DE69010199D1 (de) 1994-07-28
KR920701241A (ko) 1992-08-11
EG19583A (en) 1995-09-30
AU631641B2 (en) 1992-12-03
GB8909836D0 (en) 1989-06-14
FI914995A0 (fi) 1991-10-23
CA2056402C (en) 1999-11-16
JPH04506003A (ja) 1992-10-22
GR1001011B (el) 1993-03-31
DD296960A5 (de) 1991-12-19
YU87090A (sh) 1992-09-07
ZA903228B (en) 1990-12-28
RO112032B1 (ro) 1997-04-30
BG60916B1 (bg) 1996-06-28
LTIP1645A (en) 1995-07-25
DE69010199T2 (de) 1994-10-13
CN1047340A (zh) 1990-11-28
NO914206L (no) 1991-12-17
RU2074891C1 (ru) 1997-03-10
PT93921A (pt) 1990-11-20
IE901538L (en) 1990-10-28
IL94227A0 (en) 1991-01-31
IE64351B1 (en) 1995-07-26
PT93921B (pt) 1996-10-31
IL94227A (en) 1994-12-29
PL166810B1 (pl) 1995-06-30
GR900100315A (en) 1991-09-27
IN173230B (lv) 1994-03-12
MX20503A (es) 1993-12-01
CA2056402A1 (en) 1990-10-29
EP0470136B1 (en) 1994-06-22
HUT58345A (en) 1992-02-28
EP0470136A1 (en) 1992-02-12
HU903342D0 (en) 1992-01-28
LV10200B (en) 1995-04-20
LT3827B (en) 1996-03-25
NZ233475A (en) 1991-10-25
ES2055427T3 (es) 1994-08-16
US5468480A (en) 1995-11-21
WO1990013561A1 (en) 1990-11-15
AU5547290A (en) 1990-11-29

Similar Documents

Publication Publication Date Title
LV10200A (lv) Himopapains to saturosas farmaceitiskas kompozicijas to pielietojums panemiens himopapaina attirisanai inhibejosie peptidi un afinas hromatografijas matricas
MY129998A (en) Saccharin derivative proteolytic enzyme inhibitors
MY110104A (en) Saccharin derivative proteolytic enzyme inhibitors
UA29450C2 (uk) Похідні гідроксамової кислоти, спосіб їх одержання, спосіб впливу на хвороби та фармацевтична або ветеринарна композиція, що їх містить
GB2303629B (en) Hydroxamic acids and their use as metalloproteinase inhibitors
PL319503A1 (en) Peptide compounds and their therapeutic application as inhibitors
ES8800050A1 (es) Un procedimiento para la preparacion de derivados de cetona electrofilicos activados de sustratos de peptidasa, utiles en la inhibicion de enzimas proteasas
CA2200192A1 (en) Amidino and Guanidino Substituted Inhibitors of Trypsin-Like Enzymes
IL108797A0 (en) Amino acid derivatives, their preparation and pharmaceutical compositions containing them
HUP0004282A2 (hu) 2-Halogén-6-0-szubsztituált ketolidszármazékok
LTIP610A (en) Inhibitors of cells proliferation, pharmaceutical composition and method for preparation of compounds
NZ215282A (en) Peptide amino alcohol, renin and acid protease inhibitors, preparation and pharmaceutical composition
Eppstein et al. Cordycepin analogs of ppp5'A2 ‘p5'A2 ‘p5'A (2-5A) inhibit protein synthesis through activation of the 2-5A-dependent endonuclease.
PL307864A1 (en) Retroviral infection inhibition
ES8305414A1 (es) Procedimiento microbiologico para la obtencion de un nuevo compuesto antibiotico de la cepa streptomyces.
FR2754824B1 (fr) Nouvelle composition contenant du chitosan
GEP20022764B (en) HIV Protease Inhibitors, Pharmaceutical Compositions and Methods for Inhibiting HIV Protease
DE69011692D1 (de) Therapeutische mittel.
GEP20012440B (en) Biphenylsulfonamide Matrix Metalloproteinase Inhibitors